Tsantes, Elena http://orcid.org/0000-0002-0388-197X
Curti, E.
Ganazzoli, C.
Puci, F.
Bazzurri, V.
Fiore, A.
Crisi, G.
Granella, F.
Article History
Received: 10 April 2020
Revised: 3 May 2020
Accepted: 5 May 2020
First Online: 12 May 2020
Compliance with ethical standards
:
: E. Tsantes served on scientific advisory boards for Roche, Almirall and Merck & Co; has received funding for travel from Biogen, Merck & Co, Sanofi Genzyme, Roche, Novartis and Mylan. E. Curti served on scientific advisory boards for Merck & Co and Novartis; has received funding for travel from Biogen, Merck & Co, Teva Pharmaceutical Industries, Sanofi Genzyme, Roche and Novartis. C. Ganazzoli has nothing to disclose. F. Puci has nothing to disclose. V. Bazzurri has received funding for travel from Sanofi Genzyme, Biogen and Roche. A. Fiore has received funding for travel from Sanofi Genzyme and Biogen. G. Crisi has nothing to disclose. F. Granella has received research grants for his Institution from Biogen and Sanofi Genzyme; has served on scientific advisory boards for Biogen, Novartis, Sanofi Genzyme, Roche and Merck Serono; and has received funding for travel from Biogen, Merck Serono and Sanofi Genzyme.
: The study was approved by the local ethics committee (Comitato Etico Area Vasta Emilia Nord, 484/2018/OSS/AOUPR) and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All the patients provided written informed consent.